Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MDM2 Proto-Oncogene (None)
- Target
- None
- Molecular classification
- E3 Ubiquitin Ligase, Transcription factor regulator
01
Overview
The MDM2 proto-oncogene encodes an E3 ubiquitin-protein ligase that primarily regulates the p53 tumor suppressor protein by targeting it for proteasomal degradation. It inhibits p53’s transcriptional activity, promoting cell survival and proliferation. Overexpression or amplification of MDM2 is frequently observed in various cancers, making it a significant target for anti-cancer drug development.
- Other names
- E3 ubiquitin-protein ligase Mdm2p53-binding protein Mdm2RING-type E3 ubiquitin transferase Mdm2Hdm2 (human homolog)Double minute 2 protein
02
Mechanism of action
Inhibition of MDM2-p53 interaction, leading to p53 activation
03
Biological functions
Negative regulation of TP53/p53Regulation of apoptosisCell cycle controlDNA damage responseProtein ubiquitinationRegulation of cell proliferation
04
Disease associations
CancerLessel-Kubisch SyndromeDedifferentiated liposarcomaDrug resistance in cancer
05
Safety considerations
Potential for off-target effectsDevelopment of resistanceComplex regulatory pathways
Beyond the preview
Go deeper on MDM2 Proto-Oncogene (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MDM2 Proto-Oncogene (None).